Nouritza M. Torossian

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Calcium scoring during 18F-FDG PET/CT in cancer indications: Improving cardiovascular risk stratification and prevention.

Calcium scoring during 18F-FDG PET/CT in cancer indications: Improving cardiovascular risk stratification and prevention.

Journal: PloS one

Published: July 19, 2025

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

Journal: NAR cancer

Published: March 06, 2025

False-positive 16α-[18F]Fluoro-17β-Estradiol PET/CT in benign cartilaginous tumor.

False-positive 16α-[18F]Fluoro-17β-Estradiol PET/CT in benign cartilaginous tumor.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 05, 2024

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.

Journal: British journal of cancer

Published: February 08, 2023

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.

Journal: Drugs in R&D

Published: September 01, 2021

Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.

Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 06, 2021

Advances in theranostic biomarkers for tumor immunotherapy.

Advances in theranostic biomarkers for tumor immunotherapy.

Journal: Current opinion in chemical biology

Published: September 12, 2019

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 19, 2019

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma.

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma.

Journal: JNCI cancer spectrum

Published: April 09, 2019

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy.

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy.

Journal: British journal of cancer

Published: February 14, 2018

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Journal: Oncotarget

Published: November 11, 2017

Metastasis of ciliary body melanoma to the contralateral eye: a case report and review of uveal melanoma literature.

Metastasis of ciliary body melanoma to the contralateral eye: a case report and review of uveal melanoma literature.

Journal: Case reports in oncological medicine

Published: November 07, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026